Compare Entergy Corporation (ETR) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entergy Corporation vs ResMed Inc. — how do they compare? Entergy Corporation trades at $102.9 (market cap $49.52B), while ResMed Inc. trades at $228.63 (market cap $32.17B). The key difference: Entergy Corporation is the larger of the two by market cap, and Entergy Corporation pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| ETR | RMD | |
|---|---|---|
Market Cap | $49.52B | $32.17B |
Sector | Utilities | Health |
52-Week High | $117.91 | $283.28 |
52-Week Low | $87.83 | $182.82 |
Enterprise Value | $80.29B | $31.52B |
Dividend Yield | 2.47% | 1.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Entergy Corporation (ETR) trades at $102.92, down 2.29% with a bearish technical outlook. The stock shows mixed earnings performance with recent beats but faces technical headwinds. Fundamentally, the company maintains solid profitability with 13.48% net margins and benefits from growing data center agreements. Analyst consensus remains strongly bullish with a $123.60 price target, representing 20% upside potential from current levels.
The investment case balances strong institutional support and dividend stability against technical weakness and execution risks. Upside catalysts include data center revenue growth and regulatory approvals, while risks involve interest expense pressure and competitive threats. Wall Street's unanimous buy/hold ratings suggest confidence in long-term value despite near-term volatility.
ResMed (RMD) trades at $229.50, up 5.15% today, near the consensus price target of $235.70. The stock shows strong fundamentals with consistent earnings beats, robust profitability margins, and healthy cash flow growth. However, technical indicators signal a bearish trend, and recent news highlights investor concerns over weak 2027 revenue guidance and a legal investigation, tempering near-term optimism.
The outlook is mixed: solid earnings growth and high margins support upside potential, but bearish technicals and guidance risks pose headwinds. Investors should weigh strong fundamentals against sentiment-driven volatility and legal overhangs for balanced positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Entergy Corporation
Entergy is an energy company that operates regulated electric utilities and power generation businesses in the United States. Its generation portfolio includes nuclear, natural gas, and renewable resources.
Read more on ETR →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
